BAP1 and cutaneous melanoma: BIMs were originally described in patients with germline inactivating BAP1 mutations, which cause an autosomal dominant tumour predisposition syndrome with increased risk of uveal melanoma, mesothelioma, meningioma, renal cell carcinoma, and cutaneous melanoma.6, 7, 8